May 02, 2020

The dropless future: SLT as a first-line treatment for glaucoma Drop tolerance and adherence are glaucoma medication challenges that physicians and their patients have wrestled with for years. But with advances in laser technology improving laser safety and recent research demonstrating SLT efficacy and safety, drops do not have to be the first line of treatment. Find out ADVERTISEMENT   Pharmacologic treatment an option for open-angle glaucoma While patient compliance remains a challenge, new agents on the horizon are offering hope in the field of glaucoma Find out more ADVERTISEMENT   Genetics analysis may predict myopia in children Clinicians may soon be able to use genetic information alone to determine the risk of myopia in very young children, researchers believe. Read more ADVERTISEMENT   RELATED ARTICLES   Putting technologies into practice not perfect science Diagnosing LSCD noninvasively: SD-OCT preferred technology Researchers eye cure, diagnostics for adenoviral conjunctivitis Fluorescein angiography key in diagnosing retinal diseases Corneal ectasia: Effects of epi-on and epi-off CXL Caution key when embracing new technologies in clinical practice Improving LASIK outcomes with biomechanical analysis Astigmatism: A ‘clear-as-mud’ concept to patients